These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37977318)

  • 41. Fundamental changes in endogenous bone marrow mesenchymal stromal cells during Type I Diabetes is a pre-neuropathy event.
    Shahani P; Mahadevan A; Datta I
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166187. PubMed ID: 34102256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells.
    Kubota K; Nakano M; Kobayashi E; Mizue Y; Chikenji T; Otani M; Nagaishi K; Fujimiya M
    PLoS One; 2018; 13(9):e0204252. PubMed ID: 30240403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats.
    Othman AI; El-Sawi MR; El-Missiry MA; Abukhalil MH
    Biomed Pharmacother; 2017 Oct; 94():362-373. PubMed ID: 28772214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells.
    Ezquer F; Ezquer M; Simon V; Conget P
    PLoS One; 2011 Jan; 6(1):e16566. PubMed ID: 21304603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Receptor for Advanced Glycation End Products-Mediated Signaling Impairs the Maintenance of Bone Marrow Mesenchymal Stromal Cells in Diabetic Model Mice.
    Aikawa E; Fujita R; Asai M; Kaneda Y; Tamai K
    Stem Cells Dev; 2016 Nov; 25(22):1721-1732. PubMed ID: 27539289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigallocatechin gallate targeting of membrane type 1 matrix metalloproteinase-mediated Src and Janus kinase/signal transducers and activators of transcription 3 signaling inhibits transcription of colony-stimulating factors 2 and 3 in mesenchymal stromal cells.
    Zgheib A; Lamy S; Annabi B
    J Biol Chem; 2013 May; 288(19):13378-86. PubMed ID: 23548906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identical, similar or different? Learning about immunomodulatory function of mesenchymal stem cells isolated from various mouse tissues: bone marrow, spleen, thymus and aorta wall.
    Hegyi B; Sági B; Kovács J; Kiss J; Urbán VS; Mészáros G; Monostori E; Uher F
    Int Immunol; 2010 Jul; 22(7):551-9. PubMed ID: 20497958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens.
    Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB
    Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cooperation by fibroblasts and bone marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse islet xenotransplantation.
    Perez-Basterrechea M; Obaya AJ; Meana A; Otero J; Esteban MM
    PLoS One; 2013; 8(8):e73526. PubMed ID: 24009755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study.
    Jin P; Wu H; Xu G; Zheng L; Zhao J
    Cell Tissue Res; 2014 May; 356(2):381-90. PubMed ID: 24682582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced regulatory effects of bone marrow-derived mesenchymal stem cells on activated T lymphocytes and Th1/Th2 cytokine secretion in children with aplastic anemia.
    Guo X; Weng W; Wang Y; Pan J; Li S; Chen Y; Song H; Zhang J; Xu W; Xu X; Tang Y
    Clin Exp Med; 2023 Dec; 23(8):4633-4646. PubMed ID: 37930604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect and mechanisms of human Wharton's jelly-derived mesenchymal stem cells on type 1 diabetes in NOD model.
    Hu J; Wang Y; Wang F; Wang L; Yu X; Sun R; Wang Z; Wang L; Gao H; Fu Z; Zhao W; Yan S
    Endocrine; 2015 Feb; 48(1):124-34. PubMed ID: 24590294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AD-MSCs and BM-MSCs Ameliorating Effects on The Metabolic and Hepato-renal Abnormalities in Type 1 Diabetic Rats.
    El-Sawah SG; Rashwan HM; Althobaiti F; Aldhahrani A; Fayad E; Shabana ES; El-Hallous EI; Amen RM
    Saudi J Biol Sci; 2022 Feb; 29(2):1053-1060. PubMed ID: 35197774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells to Treat Type 1 Diabetic Mellitus in Mice: An Evaluation of Grafted Cell Doses.
    Dang LT; Bui AN; Le-Thanh Nguyen C; Truong NC; Bui AT; Kim NP; Truong KD; Van Pham P
    Adv Exp Med Biol; 2018; 1083():145-156. PubMed ID: 29423674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Control of Hyperglycemia Using Differentiated and Undifferentiated Mesenchymal Stem Cells in Rats with Type 1 Diabetes.
    Aali E; Madjd Z; Tekiyehmaroof N; Sharifi AM
    Cells Tissues Organs; 2020; 209(1):13-25. PubMed ID: 32634811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigallocatechin gallate/L-ascorbic acid-loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis.
    Chiu YH; Wu YW; Hung JI; Chen MC
    Acta Biomater; 2021 Aug; 130():223-233. PubMed ID: 34087444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antioxidant Preconditioning Improves the Paracrine Responsiveness of Mouse Bone Marrow Mesenchymal Stem Cells to Diabetic Wound Fluid.
    Mehrbani Azar Y; Green R; Niesler CU; van de Vyver M
    Stem Cells Dev; 2018 Dec; 27(23):1646-1657. PubMed ID: 30187827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study on the therapeutic effects of bone marrow mesenchymal stem cells versus platelet rich plasma on the pancreas of adult male albino rats with streptozotocin-induced type 1 diabetes mellitus.
    El-Haroun H; Salama RM
    Folia Morphol (Warsz); 2022; 81(1):65-81. PubMed ID: 33559114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM; Hegab AS; Al-Shahat A; Raafat N
    Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.